Market Overview

Endologix to Host Investor Meeting on October 2, 2018


Endologix, Inc. (NASDAQ:ELGX) ("Endologix" or the "Company"), a
developer and marketer of innovative treatments for aortic disorders,
today announced that it will host a meeting for financial analysts and
investment professionals at 4:15 p.m. ET on Tuesday, October 2, 2018, at
The London Hotel NYC, 151 W. 54th St., New York, NY 10019.

The preliminary agenda for the event includes:

4:15 p.m. – 6:00 p.m. ET             Management strategic and financial presentations, physician
presentations, Q&A
6:00 p.m. – 7:00 p.m. ET Product showcase of Endologix devices

Participants may register for the meeting here.


For those unable to attend in person, a live webcast of the
presentations will begin at 4:15 p.m. ET, and will be available on the
"Investors" section of the Company's website at
Following the event, a replay of the presentation and the associated
materials will be available on the same site.

About Endologix, Inc.

Endologix, Inc. develops and manufactures minimally invasive treatments
for aortic disorders. The Company's focus is endovascular stent grafts
for the treatment of abdominal aortic aneurysms (AAA). AAA is a
weakening of the wall of the aorta, the largest artery in the body,
resulting in a balloon-like enlargement. Once AAA develops, it continues
to enlarge and, if left untreated, becomes increasingly susceptible to
rupture. The overall patient mortality rate for ruptured AAA is
approximately 80%, making it a leading cause of death in the United
States. For more information, visit

View Comments and Join the Discussion!